nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—CYP2D6—breast cancer	0.0597	0.389	CbGaD
Doxepin—CYP3A4—breast cancer	0.0512	0.333	CbGaD
Doxepin—ABCB1—breast cancer	0.0426	0.278	CbGaD
Doxepin—Doxylamine—Toremifene—breast cancer	0.04	0.12	CrCrCtD
Doxepin—Bromodiphenhydramine—Toremifene—breast cancer	0.0338	0.101	CrCrCtD
Doxepin—HTR6—Raloxifene—breast cancer	0.0316	0.113	CbGbCtD
Doxepin—HTR2B—Raloxifene—breast cancer	0.0283	0.101	CbGbCtD
Doxepin—Clofedanol—Toremifene—breast cancer	0.0274	0.0823	CrCrCtD
Doxepin—Cyclobenzaprine—Tamoxifen—breast cancer	0.0273	0.0819	CrCrCtD
Doxepin—Orphenadrine—Toremifene—breast cancer	0.0266	0.0796	CrCrCtD
Doxepin—Doxylamine—Tamoxifen—breast cancer	0.0251	0.0753	CrCrCtD
Doxepin—Diphenhydramine—Toremifene—breast cancer	0.0236	0.0707	CrCrCtD
Doxepin—Tripelennamine—Tamoxifen—breast cancer	0.0227	0.0681	CrCrCtD
Doxepin—Bromodiphenhydramine—Tamoxifen—breast cancer	0.0212	0.0636	CrCrCtD
Doxepin—Dimetacrine—Tamoxifen—breast cancer	0.0212	0.0636	CrCrCtD
Doxepin—Clofedanol—Tamoxifen—breast cancer	0.0172	0.0517	CrCrCtD
Doxepin—Orphenadrine—Tamoxifen—breast cancer	0.0167	0.05	CrCrCtD
Doxepin—Promazine—Tamoxifen—breast cancer	0.0159	0.0477	CrCrCtD
Doxepin—Diphenhydramine—Tamoxifen—breast cancer	0.0148	0.0444	CrCrCtD
Doxepin—CYP1A2—Anastrozole—breast cancer	0.0132	0.0473	CbGbCtD
Doxepin—CYP1A2—Toremifene—breast cancer	0.0121	0.0433	CbGbCtD
Doxepin—CYP2C9—Anastrozole—breast cancer	0.0119	0.0427	CbGbCtD
Doxepin—ABCB1—Toremifene—breast cancer	0.0106	0.0379	CbGbCtD
Doxepin—CYP2C19—Lapatinib—breast cancer	0.00957	0.0342	CbGbCtD
Doxepin—CYP3A4—Exemestane—breast cancer	0.00915	0.0327	CbGbCtD
Doxepin—CYP2C9—Idarubicin—breast cancer	0.00904	0.0323	CbGbCtD
Doxepin—CYP2D6—Idarubicin—breast cancer	0.00826	0.0296	CbGbCtD
Doxepin—CYP3A4—Letrozole—breast cancer	0.00778	0.0278	CbGbCtD
Doxepin—ABCB1—Lapatinib—breast cancer	0.00772	0.0276	CbGbCtD
Doxepin—CYP3A4—Anastrozole—breast cancer	0.00693	0.0248	CbGbCtD
Doxepin—CYP3A4—Toremifene—breast cancer	0.00634	0.0227	CbGbCtD
Doxepin—CYP3A4—Fulvestrant—breast cancer	0.00589	0.0211	CbGbCtD
Doxepin—CYP3A4—Thiotepa—breast cancer	0.00525	0.0188	CbGbCtD
Doxepin—CYP2C9—Capecitabine—breast cancer	0.00495	0.0177	CbGbCtD
Doxepin—CYP3A4—Ixabepilone—breast cancer	0.00481	0.0172	CbGbCtD
Doxepin—CYP2C19—Tamoxifen—breast cancer	0.00479	0.0171	CbGbCtD
Doxepin—CYP3A4—Lapatinib—breast cancer	0.00463	0.0166	CbGbCtD
Doxepin—CYP1A2—Tamoxifen—breast cancer	0.00442	0.0158	CbGbCtD
Doxepin—ABCB1—Vinorelbine—breast cancer	0.00428	0.0153	CbGbCtD
Doxepin—CYP2D6—Vinorelbine—breast cancer	0.00403	0.0144	CbGbCtD
Doxepin—CYP2C9—Tamoxifen—breast cancer	0.00398	0.0143	CbGbCtD
Doxepin—ABCB1—Tamoxifen—breast cancer	0.00387	0.0138	CbGbCtD
Doxepin—ABCB1—Mitoxantrone—breast cancer	0.00377	0.0135	CbGbCtD
Doxepin—CYP2D6—Tamoxifen—breast cancer	0.00364	0.013	CbGbCtD
Doxepin—CYP3A4—Raloxifene—breast cancer	0.00351	0.0125	CbGbCtD
Doxepin—ABCB1—Gemcitabine—breast cancer	0.00333	0.0119	CbGbCtD
Doxepin—CYP1A2—Fluorouracil—breast cancer	0.00326	0.0117	CbGbCtD
Doxepin—CYP2C9—Paclitaxel—breast cancer	0.0031	0.0111	CbGbCtD
Doxepin—ABCB1—Paclitaxel—breast cancer	0.00301	0.0108	CbGbCtD
Doxepin—ABCB1—Irinotecan—breast cancer	0.00297	0.0106	CbGbCtD
Doxepin—CYP2C9—Fluorouracil—breast cancer	0.00294	0.0105	CbGbCtD
Doxepin—ABCB1—Vinblastine—breast cancer	0.00264	0.00944	CbGbCtD
Doxepin—CYP3A4—Vinorelbine—breast cancer	0.00257	0.00918	CbGbCtD
Doxepin—CYP2D6—Vinblastine—breast cancer	0.00249	0.0089	CbGbCtD
Doxepin—CYP3A4—Tamoxifen—breast cancer	0.00232	0.00829	CbGbCtD
Doxepin—CYP3A4—Mitoxantrone—breast cancer	0.00226	0.00808	CbGbCtD
Doxepin—ABCB1—Docetaxel—breast cancer	0.00218	0.00778	CbGbCtD
Doxepin—CHRM3—muscle of abdomen—breast cancer	0.00215	0.0968	CbGeAlD
Doxepin—CYP3A4—Paclitaxel—breast cancer	0.0018	0.00645	CbGbCtD
Doxepin—CYP3A4—Irinotecan—breast cancer	0.00178	0.00636	CbGbCtD
Doxepin—ABCB1—Doxorubicin—breast cancer	0.00162	0.0058	CbGbCtD
Doxepin—CYP3A4—Vinblastine—breast cancer	0.00158	0.00566	CbGbCtD
Doxepin—ABCB1—Methotrexate—breast cancer	0.00157	0.00562	CbGbCtD
Doxepin—CYP2D6—Doxorubicin—breast cancer	0.00153	0.00547	CbGbCtD
Doxepin—CYP3A4—Docetaxel—breast cancer	0.0013	0.00466	CbGbCtD
Doxepin—CYP3A4—Doxorubicin—breast cancer	0.000972	0.00348	CbGbCtD
Doxepin—HRH4—bone marrow—breast cancer	0.0008	0.036	CbGeAlD
Doxepin—CHRM5—epithelium—breast cancer	0.000457	0.0206	CbGeAlD
Doxepin—HRH2—skin of body—breast cancer	0.000455	0.0205	CbGeAlD
Doxepin—CHRM5—skin of body—breast cancer	0.000435	0.0196	CbGeAlD
Doxepin—ADRA1D—epithelium—breast cancer	0.000409	0.0184	CbGeAlD
Doxepin—HRH2—adrenal gland—breast cancer	0.000347	0.0156	CbGeAlD
Doxepin—Dimetacrine—ACHE—breast cancer	0.000337	0.179	CrCbGaD
Doxepin—KCNH2—nipple—breast cancer	0.000337	0.0152	CbGeAlD
Doxepin—ADRA2C—nipple—breast cancer	0.000332	0.015	CbGeAlD
Doxepin—CYP2C9—mammary gland—breast cancer	0.000331	0.0149	CbGeAlD
Doxepin—ADRA1D—female reproductive system—breast cancer	0.000304	0.0137	CbGeAlD
Doxepin—ORM1—endometrium—breast cancer	0.000302	0.0136	CbGeAlD
Doxepin—HRH2—endocrine gland—breast cancer	0.000301	0.0136	CbGeAlD
Doxepin—CYP1A2—nipple—breast cancer	0.000288	0.013	CbGeAlD
Doxepin—HTR2B—skin of body—breast cancer	0.00027	0.0122	CbGeAlD
Doxepin—HRH1—nipple—breast cancer	0.00027	0.0122	CbGeAlD
Doxepin—ADRA2A—nipple—breast cancer	0.000265	0.0119	CbGeAlD
Doxepin—ADRA1D—endocrine gland—breast cancer	0.000257	0.0116	CbGeAlD
Doxepin—HTR2B—endometrium—breast cancer	0.000255	0.0115	CbGeAlD
Doxepin—ORM1—female reproductive system—breast cancer	0.00025	0.0113	CbGeAlD
Doxepin—ORM1—bone marrow—breast cancer	0.000236	0.0106	CbGeAlD
Doxepin—HTR2B—uterus—breast cancer	0.000235	0.0106	CbGeAlD
Doxepin—ADRA1A—epithelium—breast cancer	0.000235	0.0106	CbGeAlD
Doxepin—HTR2B—adipose tissue—breast cancer	0.00023	0.0103	CbGeAlD
Doxepin—HTR2C—female reproductive system—breast cancer	0.000225	0.0101	CbGeAlD
Doxepin—SLC6A4—female reproductive system—breast cancer	0.000213	0.0096	CbGeAlD
Doxepin—CHRM1—female reproductive system—breast cancer	0.000212	0.00956	CbGeAlD
Doxepin—ORM1—endocrine gland—breast cancer	0.000212	0.00953	CbGeAlD
Doxepin—HTR2B—female reproductive system—breast cancer	0.000211	0.00951	CbGeAlD
Doxepin—HRH2—lymph node—breast cancer	0.000208	0.00937	CbGeAlD
Doxepin—CHRM3—adipose tissue—breast cancer	0.000207	0.00931	CbGeAlD
Doxepin—HTR2B—adrenal gland—breast cancer	0.000206	0.00928	CbGeAlD
Doxepin—KCNH2—endometrium—breast cancer	0.000203	0.00916	CbGeAlD
Doxepin—ADRA2C—endometrium—breast cancer	0.000201	0.00904	CbGeAlD
Doxepin—CHRM2—endocrine gland—breast cancer	0.000197	0.00889	CbGeAlD
Doxepin—CHRM3—female reproductive system—breast cancer	0.00019	0.00856	CbGeAlD
Doxepin—ADRA1A—adipose tissue—breast cancer	0.00019	0.00855	CbGeAlD
Doxepin—SLC6A2—female reproductive system—breast cancer	0.000188	0.00845	CbGeAlD
Doxepin—KCNH2—uterus—breast cancer	0.000187	0.00844	CbGeAlD
Doxepin—DRD2—pituitary gland—breast cancer	0.000187	0.00841	CbGeAlD
Doxepin—HTR2A—embryo—breast cancer	0.000186	0.00838	CbGeAlD
Doxepin—ADRA2C—uterus—breast cancer	0.000185	0.00833	CbGeAlD
Doxepin—HTR1A—adrenal gland—breast cancer	0.000185	0.00832	CbGeAlD
Doxepin—KCNH2—pituitary gland—breast cancer	0.000184	0.00829	CbGeAlD
Doxepin—SLC6A2—adrenal gland—breast cancer	0.000183	0.00825	CbGeAlD
Doxepin—HRH1—epithelium—breast cancer	0.000182	0.00819	CbGeAlD
Doxepin—ADRA2C—pituitary gland—breast cancer	0.000182	0.00818	CbGeAlD
Doxepin—ADRA2C—adipose tissue—breast cancer	0.000181	0.00814	CbGeAlD
Doxepin—SLC6A4—endocrine gland—breast cancer	0.00018	0.00812	CbGeAlD
Doxepin—CHRM1—endocrine gland—breast cancer	0.00018	0.00809	CbGeAlD
Doxepin—CHRM3—female gonad—breast cancer	0.000173	0.00779	CbGeAlD
Doxepin—ADRA1A—adrenal gland—breast cancer	0.00017	0.00767	CbGeAlD
Doxepin—KCNH2—female reproductive system—breast cancer	0.000168	0.00759	CbGeAlD
Doxepin—KCNH2—adrenal gland—breast cancer	0.000164	0.0074	CbGeAlD
Doxepin—HRH1—endometrium—breast cancer	0.000163	0.00734	CbGeAlD
Doxepin—ADRA2C—adrenal gland—breast cancer	0.000162	0.00731	CbGeAlD
Doxepin—CHRM3—endocrine gland—breast cancer	0.000161	0.00724	CbGeAlD
Doxepin—HTR1A—endocrine gland—breast cancer	0.00016	0.00721	CbGeAlD
Doxepin—ADRA2A—endometrium—breast cancer	0.00016	0.00721	CbGeAlD
Doxepin—KCNH2—bone marrow—breast cancer	0.000159	0.00716	CbGeAlD
Doxepin—SLC6A2—endocrine gland—breast cancer	0.000159	0.00715	CbGeAlD
Doxepin—KCNH2—female gonad—breast cancer	0.000153	0.0069	CbGeAlD
Doxepin—HTR2A—epithelium—breast cancer	0.000152	0.00684	CbGeAlD
Doxepin—ADRA2C—female gonad—breast cancer	0.000151	0.00681	CbGeAlD
Doxepin—CYP2C19—endocrine gland—breast cancer	0.000149	0.00673	CbGeAlD
Doxepin—ADRA1A—endocrine gland—breast cancer	0.000148	0.00665	CbGeAlD
Doxepin—ADRA2A—uterus—breast cancer	0.000147	0.00664	CbGeAlD
Doxepin—HRH1—adipose tissue—breast cancer	0.000147	0.00662	CbGeAlD
Doxepin—ORM1—lymph node—breast cancer	0.000146	0.00659	CbGeAlD
Doxepin—ADRA2A—pituitary gland—breast cancer	0.000145	0.00653	CbGeAlD
Doxepin—DRD2—endocrine gland—breast cancer	0.000145	0.00652	CbGeAlD
Doxepin—ADRA2A—adipose tissue—breast cancer	0.000144	0.0065	CbGeAlD
Doxepin—KCNH2—endocrine gland—breast cancer	0.000143	0.00642	CbGeAlD
Doxepin—CYP2C9—female reproductive system—breast cancer	0.000137	0.00617	CbGeAlD
Doxepin—HRH1—female reproductive system—breast cancer	0.000135	0.00608	CbGeAlD
Doxepin—ADRA2A—female reproductive system—breast cancer	0.000133	0.00597	CbGeAlD
Doxepin—HRH1—adrenal gland—breast cancer	0.000132	0.00593	CbGeAlD
Doxepin—ADRA2A—adrenal gland—breast cancer	0.000129	0.00583	CbGeAlD
Doxepin—HTR2B—lymph node—breast cancer	0.000124	0.00556	CbGeAlD
Doxepin—HTR2A—pituitary gland—breast cancer	0.000123	0.00555	CbGeAlD
Doxepin—HRH1—female gonad—breast cancer	0.000123	0.00553	CbGeAlD
Doxepin—CYP1A2—endocrine gland—breast cancer	0.000122	0.0055	CbGeAlD
Doxepin—ABCB1—embryo—breast cancer	0.000122	0.00549	CbGeAlD
Doxepin—ADRA2A—female gonad—breast cancer	0.000121	0.00544	CbGeAlD
Doxepin—CYP2C9—endocrine gland—breast cancer	0.000116	0.00522	CbGeAlD
Doxepin—HRH1—endocrine gland—breast cancer	0.000114	0.00515	CbGeAlD
Doxepin—HTR2A—female reproductive system—breast cancer	0.000113	0.00508	CbGeAlD
Doxepin—ADRA2A—endocrine gland—breast cancer	0.000112	0.00505	CbGeAlD
Doxepin—HTR2A—adrenal gland—breast cancer	0.00011	0.00496	CbGeAlD
Doxepin—SLC6A2—lymph node—breast cancer	0.00011	0.00494	CbGeAlD
Doxepin—CYP3A4—female reproductive system—breast cancer	0.000104	0.0047	CbGeAlD
Doxepin—Orphenadrine—SCN10A—breast cancer	0.000104	0.0549	CrCbGaD
Doxepin—CYP2D6—female reproductive system—breast cancer	0.000103	0.00463	CbGeAlD
Doxepin—ABCB1—epithelium—breast cancer	9.95e-05	0.00448	CbGeAlD
Doxepin—Clomipramine—GSTP1—breast cancer	9.88e-05	0.0524	CrCbGaD
Doxepin—KCNH2—lymph node—breast cancer	9.85e-05	0.00444	CbGeAlD
Doxepin—ADRA2C—lymph node—breast cancer	9.72e-05	0.00438	CbGeAlD
Doxepin—HTR2A—endocrine gland—breast cancer	9.54e-05	0.0043	CbGeAlD
Doxepin—CYP2D6—female gonad—breast cancer	9.35e-05	0.00421	CbGeAlD
Doxepin—ABCB1—endometrium—breast cancer	8.92e-05	0.00402	CbGeAlD
Doxepin—CYP3A4—endocrine gland—breast cancer	8.83e-05	0.00398	CbGeAlD
Doxepin—CYP2D6—endocrine gland—breast cancer	8.69e-05	0.00392	CbGeAlD
Doxepin—Tripelennamine—CYP2D6—breast cancer	8.52e-05	0.0452	CrCbGaD
Doxepin—ABCB1—uterus—breast cancer	8.22e-05	0.0037	CbGeAlD
Doxepin—ABCB1—pituitary gland—breast cancer	8.07e-05	0.00364	CbGeAlD
Doxepin—ABCB1—adipose tissue—breast cancer	8.04e-05	0.00362	CbGeAlD
Doxepin—HRH1—lymph node—breast cancer	7.9e-05	0.00356	CbGeAlD
Doxepin—ADRA2A—lymph node—breast cancer	7.76e-05	0.00349	CbGeAlD
Doxepin—ABCB1—female reproductive system—breast cancer	7.39e-05	0.00333	CbGeAlD
Doxepin—Olopatadine—CYP3A4—breast cancer	7.23e-05	0.0383	CrCbGaD
Doxepin—ABCB1—adrenal gland—breast cancer	7.21e-05	0.00325	CbGeAlD
Doxepin—Cyclobenzaprine—CYP2D6—breast cancer	7.08e-05	0.0376	CrCbGaD
Doxepin—ABCB1—bone marrow—breast cancer	6.97e-05	0.00314	CbGeAlD
Doxepin—ABCB1—female gonad—breast cancer	6.72e-05	0.00303	CbGeAlD
Doxepin—Alimemazine—CYP3A4—breast cancer	6.6e-05	0.035	CrCbGaD
Doxepin—ABCB1—endocrine gland—breast cancer	6.25e-05	0.00282	CbGeAlD
Doxepin—Cyclobenzaprine—CYP3A4—breast cancer	6.08e-05	0.0322	CrCbGaD
Doxepin—Oxcarbazepine—CYP3A4—breast cancer	5.56e-05	0.0295	CrCbGaD
Doxepin—Nortriptyline—PTGS1—breast cancer	5.34e-05	0.0283	CrCbGaD
Doxepin—Diphenhydramine—PTGS1—breast cancer	4.94e-05	0.0262	CrCbGaD
Doxepin—Oxcarbazepine—ALB—breast cancer	4.85e-05	0.0257	CrCbGaD
Doxepin—Thiothixene—CYP2D6—breast cancer	4.71e-05	0.025	CrCbGaD
Doxepin—ABCB1—lymph node—breast cancer	4.32e-05	0.00195	CbGeAlD
Doxepin—Clomipramine—CYP2D6—breast cancer	3.72e-05	0.0197	CrCbGaD
Doxepin—Nortriptyline—CYP2D6—breast cancer	3.64e-05	0.0193	CrCbGaD
Doxepin—Thiothixene—ALB—breast cancer	3.52e-05	0.0187	CrCbGaD
Doxepin—Trimipramine—CYP2D6—breast cancer	3.42e-05	0.0182	CrCbGaD
Doxepin—Diphenhydramine—CYP2D6—breast cancer	3.36e-05	0.0178	CrCbGaD
Doxepin—Promethazine—CYP2D6—breast cancer	3.3e-05	0.0175	CrCbGaD
Doxepin—Clomipramine—CYP3A4—breast cancer	3.19e-05	0.0169	CrCbGaD
Doxepin—Nortriptyline—CYP3A4—breast cancer	3.12e-05	0.0166	CrCbGaD
Doxepin—Desipramine—CYP2D6—breast cancer	2.99e-05	0.0159	CrCbGaD
Doxepin—Trimipramine—CYP3A4—breast cancer	2.94e-05	0.0156	CrCbGaD
Doxepin—Clomipramine—ALB—breast cancer	2.78e-05	0.0148	CrCbGaD
Doxepin—Orphenadrine—CYP3A4—breast cancer	2.73e-05	0.0145	CrCbGaD
Doxepin—Nortriptyline—ALB—breast cancer	2.72e-05	0.0144	CrCbGaD
Doxepin—Clomipramine—ABCB1—breast cancer	2.66e-05	0.0141	CrCbGaD
Doxepin—Chlorprothixene—ABCB1—breast cancer	2.65e-05	0.014	CrCbGaD
Doxepin—Desipramine—CYP3A4—breast cancer	2.57e-05	0.0136	CrCbGaD
Doxepin—Imipramine—CYP2D6—breast cancer	2.54e-05	0.0135	CrCbGaD
Doxepin—Amitriptyline—CYP2D6—breast cancer	2.52e-05	0.0134	CrCbGaD
Doxepin—Promazine—CYP3A4—breast cancer	2.49e-05	0.0132	CrCbGaD
Doxepin—Trimipramine—ABCB1—breast cancer	2.45e-05	0.013	CrCbGaD
Doxepin—Promethazine—ABCB1—breast cancer	2.35e-05	0.0125	CrCbGaD
Doxepin—Imipramine—CYP3A4—breast cancer	2.18e-05	0.0116	CrCbGaD
Doxepin—Amitriptyline—CYP3A4—breast cancer	2.16e-05	0.0115	CrCbGaD
Doxepin—Desipramine—ABCB1—breast cancer	2.14e-05	0.0113	CrCbGaD
Doxepin—Gastrointestinal disorder—Docetaxel—breast cancer	2.04e-05	0.000151	CcSEcCtD
Doxepin—Connective tissue disorder—Doxorubicin—breast cancer	2.04e-05	0.000151	CcSEcCtD
Doxepin—Dyspnoea—Capecitabine—breast cancer	2.04e-05	0.000151	CcSEcCtD
Doxepin—Fatigue—Docetaxel—breast cancer	2.04e-05	0.000151	CcSEcCtD
Doxepin—Angiopathy—Epirubicin—breast cancer	2.04e-05	0.000151	CcSEcCtD
Doxepin—Urethral disorder—Doxorubicin—breast cancer	2.04e-05	0.000151	CcSEcCtD
Doxepin—Nausea—Mitoxantrone—breast cancer	2.03e-05	0.00015	CcSEcCtD
Doxepin—Nausea—Irinotecan—breast cancer	2.03e-05	0.00015	CcSEcCtD
Doxepin—Immune system disorder—Epirubicin—breast cancer	2.03e-05	0.00015	CcSEcCtD
Doxepin—Mediastinal disorder—Epirubicin—breast cancer	2.02e-05	0.00015	CcSEcCtD
Doxepin—Constipation—Docetaxel—breast cancer	2.02e-05	0.00015	CcSEcCtD
Doxepin—Pain—Docetaxel—breast cancer	2.02e-05	0.00015	CcSEcCtD
Doxepin—Back pain—Methotrexate—breast cancer	2.02e-05	0.00015	CcSEcCtD
Doxepin—Dyspepsia—Capecitabine—breast cancer	2.02e-05	0.000149	CcSEcCtD
Doxepin—Chills—Epirubicin—breast cancer	2.01e-05	0.000149	CcSEcCtD
Doxepin—Arrhythmia—Epirubicin—breast cancer	2.01e-05	0.000149	CcSEcCtD
Doxepin—Asthenia—Paclitaxel—breast cancer	2e-05	0.000148	CcSEcCtD
Doxepin—Decreased appetite—Capecitabine—breast cancer	1.99e-05	0.000147	CcSEcCtD
Doxepin—Alopecia—Epirubicin—breast cancer	1.98e-05	0.000147	CcSEcCtD
Doxepin—Nausea—Gemcitabine—breast cancer	1.98e-05	0.000147	CcSEcCtD
Doxepin—Gastrointestinal disorder—Capecitabine—breast cancer	1.98e-05	0.000146	CcSEcCtD
Doxepin—Fatigue—Capecitabine—breast cancer	1.97e-05	0.000146	CcSEcCtD
Doxepin—Pruritus—Paclitaxel—breast cancer	1.97e-05	0.000146	CcSEcCtD
Doxepin—Vision blurred—Methotrexate—breast cancer	1.97e-05	0.000146	CcSEcCtD
Doxepin—Mental disorder—Epirubicin—breast cancer	1.97e-05	0.000146	CcSEcCtD
Doxepin—Pain—Capecitabine—breast cancer	1.96e-05	0.000145	CcSEcCtD
Doxepin—Constipation—Capecitabine—breast cancer	1.96e-05	0.000145	CcSEcCtD
Doxepin—Erythema—Epirubicin—breast cancer	1.95e-05	0.000145	CcSEcCtD
Doxepin—Malnutrition—Epirubicin—breast cancer	1.95e-05	0.000145	CcSEcCtD
Doxepin—Feeling abnormal—Docetaxel—breast cancer	1.95e-05	0.000144	CcSEcCtD
Doxepin—Nausea—Fluorouracil—breast cancer	1.95e-05	0.000144	CcSEcCtD
Doxepin—Eye disorder—Doxorubicin—breast cancer	1.94e-05	0.000144	CcSEcCtD
Doxepin—Ill-defined disorder—Methotrexate—breast cancer	1.94e-05	0.000144	CcSEcCtD
Doxepin—Tinnitus—Doxorubicin—breast cancer	1.94e-05	0.000143	CcSEcCtD
Doxepin—Gastrointestinal pain—Docetaxel—breast cancer	1.93e-05	0.000143	CcSEcCtD
Doxepin—Anaemia—Methotrexate—breast cancer	1.93e-05	0.000143	CcSEcCtD
Doxepin—Cardiac disorder—Doxorubicin—breast cancer	1.93e-05	0.000143	CcSEcCtD
Doxepin—Flushing—Doxorubicin—breast cancer	1.93e-05	0.000143	CcSEcCtD
Doxepin—Flatulence—Epirubicin—breast cancer	1.93e-05	0.000143	CcSEcCtD
Doxepin—Tension—Epirubicin—breast cancer	1.92e-05	0.000142	CcSEcCtD
Doxepin—Dysgeusia—Epirubicin—breast cancer	1.91e-05	0.000142	CcSEcCtD
Doxepin—Diarrhoea—Paclitaxel—breast cancer	1.91e-05	0.000141	CcSEcCtD
Doxepin—Nervousness—Epirubicin—breast cancer	1.9e-05	0.000141	CcSEcCtD
Doxepin—Back pain—Epirubicin—breast cancer	1.89e-05	0.00014	CcSEcCtD
Doxepin—Amitriptyline—ALB—breast cancer	1.89e-05	0.01	CrCbGaD
Doxepin—Feeling abnormal—Capecitabine—breast cancer	1.89e-05	0.00014	CcSEcCtD
Doxepin—Angiopathy—Doxorubicin—breast cancer	1.88e-05	0.00014	CcSEcCtD
Doxepin—Malaise—Methotrexate—breast cancer	1.88e-05	0.000139	CcSEcCtD
Doxepin—Muscle spasms—Epirubicin—breast cancer	1.88e-05	0.000139	CcSEcCtD
Doxepin—Immune system disorder—Doxorubicin—breast cancer	1.88e-05	0.000139	CcSEcCtD
Doxepin—Vertigo—Methotrexate—breast cancer	1.88e-05	0.000139	CcSEcCtD
Doxepin—Gastrointestinal pain—Capecitabine—breast cancer	1.87e-05	0.000139	CcSEcCtD
Doxepin—Mediastinal disorder—Doxorubicin—breast cancer	1.87e-05	0.000139	CcSEcCtD
Doxepin—Abdominal pain—Docetaxel—breast cancer	1.87e-05	0.000138	CcSEcCtD
Doxepin—Body temperature increased—Docetaxel—breast cancer	1.87e-05	0.000138	CcSEcCtD
Doxepin—Leukopenia—Methotrexate—breast cancer	1.87e-05	0.000138	CcSEcCtD
Doxepin—Chills—Doxorubicin—breast cancer	1.86e-05	0.000138	CcSEcCtD
Doxepin—Arrhythmia—Doxorubicin—breast cancer	1.86e-05	0.000137	CcSEcCtD
Doxepin—Dizziness—Paclitaxel—breast cancer	1.84e-05	0.000137	CcSEcCtD
Doxepin—Vision blurred—Epirubicin—breast cancer	1.84e-05	0.000136	CcSEcCtD
Doxepin—Alopecia—Doxorubicin—breast cancer	1.84e-05	0.000136	CcSEcCtD
Doxepin—Cough—Methotrexate—breast cancer	1.82e-05	0.000135	CcSEcCtD
Doxepin—Mental disorder—Doxorubicin—breast cancer	1.82e-05	0.000135	CcSEcCtD
Doxepin—Urticaria—Capecitabine—breast cancer	1.82e-05	0.000135	CcSEcCtD
Doxepin—Imipramine—ABCB1—breast cancer	1.81e-05	0.00962	CrCbGaD
Doxepin—Ill-defined disorder—Epirubicin—breast cancer	1.81e-05	0.000134	CcSEcCtD
Doxepin—Abdominal pain—Capecitabine—breast cancer	1.81e-05	0.000134	CcSEcCtD
Doxepin—Body temperature increased—Capecitabine—breast cancer	1.81e-05	0.000134	CcSEcCtD
Doxepin—Convulsion—Methotrexate—breast cancer	1.81e-05	0.000134	CcSEcCtD
Doxepin—Erythema—Doxorubicin—breast cancer	1.81e-05	0.000134	CcSEcCtD
Doxepin—Malnutrition—Doxorubicin—breast cancer	1.81e-05	0.000134	CcSEcCtD
Doxepin—Anaemia—Epirubicin—breast cancer	1.81e-05	0.000134	CcSEcCtD
Doxepin—Amitriptyline—ABCB1—breast cancer	1.8e-05	0.00956	CrCbGaD
Doxepin—Agitation—Epirubicin—breast cancer	1.8e-05	0.000133	CcSEcCtD
Doxepin—Flatulence—Doxorubicin—breast cancer	1.78e-05	0.000132	CcSEcCtD
Doxepin—Arthralgia—Methotrexate—breast cancer	1.78e-05	0.000132	CcSEcCtD
Doxepin—Chest pain—Methotrexate—breast cancer	1.78e-05	0.000132	CcSEcCtD
Doxepin—Myalgia—Methotrexate—breast cancer	1.78e-05	0.000132	CcSEcCtD
Doxepin—Tension—Doxorubicin—breast cancer	1.77e-05	0.000131	CcSEcCtD
Doxepin—Vomiting—Paclitaxel—breast cancer	1.77e-05	0.000131	CcSEcCtD
Doxepin—Dysgeusia—Doxorubicin—breast cancer	1.77e-05	0.000131	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	1.77e-05	0.000131	CcSEcCtD
Doxepin—Malaise—Epirubicin—breast cancer	1.76e-05	0.000131	CcSEcCtD
Doxepin—Rash—Paclitaxel—breast cancer	1.76e-05	0.00013	CcSEcCtD
Doxepin—Dermatitis—Paclitaxel—breast cancer	1.76e-05	0.00013	CcSEcCtD
Doxepin—Discomfort—Methotrexate—breast cancer	1.76e-05	0.00013	CcSEcCtD
Doxepin—Nervousness—Doxorubicin—breast cancer	1.76e-05	0.00013	CcSEcCtD
Doxepin—Vertigo—Epirubicin—breast cancer	1.76e-05	0.00013	CcSEcCtD
Doxepin—Syncope—Epirubicin—breast cancer	1.75e-05	0.00013	CcSEcCtD
Doxepin—Leukopenia—Epirubicin—breast cancer	1.75e-05	0.00013	CcSEcCtD
Doxepin—Back pain—Doxorubicin—breast cancer	1.75e-05	0.00013	CcSEcCtD
Doxepin—Headache—Paclitaxel—breast cancer	1.75e-05	0.000129	CcSEcCtD
Doxepin—Hypersensitivity—Docetaxel—breast cancer	1.74e-05	0.000129	CcSEcCtD
Doxepin—Muscle spasms—Doxorubicin—breast cancer	1.74e-05	0.000129	CcSEcCtD
Doxepin—Palpitations—Epirubicin—breast cancer	1.73e-05	0.000128	CcSEcCtD
Doxepin—Confusional state—Methotrexate—breast cancer	1.72e-05	0.000127	CcSEcCtD
Doxepin—Loss of consciousness—Epirubicin—breast cancer	1.72e-05	0.000127	CcSEcCtD
Doxepin—Cough—Epirubicin—breast cancer	1.71e-05	0.000126	CcSEcCtD
Doxepin—Vision blurred—Doxorubicin—breast cancer	1.7e-05	0.000126	CcSEcCtD
Doxepin—Asthenia—Docetaxel—breast cancer	1.7e-05	0.000126	CcSEcCtD
Doxepin—Convulsion—Epirubicin—breast cancer	1.69e-05	0.000125	CcSEcCtD
Doxepin—Infection—Methotrexate—breast cancer	1.69e-05	0.000125	CcSEcCtD
Doxepin—Hypertension—Epirubicin—breast cancer	1.69e-05	0.000125	CcSEcCtD
Doxepin—Hypersensitivity—Capecitabine—breast cancer	1.69e-05	0.000125	CcSEcCtD
Doxepin—Ill-defined disorder—Doxorubicin—breast cancer	1.68e-05	0.000124	CcSEcCtD
Doxepin—Pruritus—Docetaxel—breast cancer	1.67e-05	0.000124	CcSEcCtD
Doxepin—Nervous system disorder—Methotrexate—breast cancer	1.67e-05	0.000124	CcSEcCtD
Doxepin—Anaemia—Doxorubicin—breast cancer	1.67e-05	0.000124	CcSEcCtD
Doxepin—Thrombocytopenia—Methotrexate—breast cancer	1.67e-05	0.000124	CcSEcCtD
Doxepin—Arthralgia—Epirubicin—breast cancer	1.66e-05	0.000123	CcSEcCtD
Doxepin—Chest pain—Epirubicin—breast cancer	1.66e-05	0.000123	CcSEcCtD
Doxepin—Myalgia—Epirubicin—breast cancer	1.66e-05	0.000123	CcSEcCtD
Doxepin—Agitation—Doxorubicin—breast cancer	1.66e-05	0.000123	CcSEcCtD
Doxepin—Anxiety—Epirubicin—breast cancer	1.66e-05	0.000123	CcSEcCtD
Doxepin—Nausea—Paclitaxel—breast cancer	1.66e-05	0.000123	CcSEcCtD
Doxepin—Skin disorder—Methotrexate—breast cancer	1.66e-05	0.000123	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	1.65e-05	0.000122	CcSEcCtD
Doxepin—Hyperhidrosis—Methotrexate—breast cancer	1.65e-05	0.000122	CcSEcCtD
Doxepin—Discomfort—Epirubicin—breast cancer	1.64e-05	0.000122	CcSEcCtD
Doxepin—Asthenia—Capecitabine—breast cancer	1.64e-05	0.000122	CcSEcCtD
Doxepin—Malaise—Doxorubicin—breast cancer	1.63e-05	0.000121	CcSEcCtD
Doxepin—Dry mouth—Epirubicin—breast cancer	1.63e-05	0.000121	CcSEcCtD
Doxepin—Vertigo—Doxorubicin—breast cancer	1.62e-05	0.00012	CcSEcCtD
Doxepin—Anorexia—Methotrexate—breast cancer	1.62e-05	0.00012	CcSEcCtD
Doxepin—Syncope—Doxorubicin—breast cancer	1.62e-05	0.00012	CcSEcCtD
Doxepin—Pruritus—Capecitabine—breast cancer	1.62e-05	0.00012	CcSEcCtD
Doxepin—Leukopenia—Doxorubicin—breast cancer	1.62e-05	0.00012	CcSEcCtD
Doxepin—Diarrhoea—Docetaxel—breast cancer	1.62e-05	0.00012	CcSEcCtD
Doxepin—Confusional state—Epirubicin—breast cancer	1.61e-05	0.000119	CcSEcCtD
Doxepin—Palpitations—Doxorubicin—breast cancer	1.6e-05	0.000118	CcSEcCtD
Doxepin—Oedema—Epirubicin—breast cancer	1.59e-05	0.000118	CcSEcCtD
Doxepin—Hypotension—Methotrexate—breast cancer	1.59e-05	0.000118	CcSEcCtD
Doxepin—Loss of consciousness—Doxorubicin—breast cancer	1.59e-05	0.000118	CcSEcCtD
Doxepin—Infection—Epirubicin—breast cancer	1.58e-05	0.000117	CcSEcCtD
Doxepin—Cough—Doxorubicin—breast cancer	1.58e-05	0.000117	CcSEcCtD
Doxepin—Shock—Epirubicin—breast cancer	1.57e-05	0.000116	CcSEcCtD
Doxepin—Convulsion—Doxorubicin—breast cancer	1.57e-05	0.000116	CcSEcCtD
Doxepin—Diarrhoea—Capecitabine—breast cancer	1.57e-05	0.000116	CcSEcCtD
Doxepin—Nervous system disorder—Epirubicin—breast cancer	1.56e-05	0.000116	CcSEcCtD
Doxepin—Dizziness—Docetaxel—breast cancer	1.56e-05	0.000116	CcSEcCtD
Doxepin—Thrombocytopenia—Epirubicin—breast cancer	1.56e-05	0.000116	CcSEcCtD
Doxepin—Hypertension—Doxorubicin—breast cancer	1.56e-05	0.000116	CcSEcCtD
Doxepin—Tachycardia—Epirubicin—breast cancer	1.56e-05	0.000115	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Methotrexate—breast cancer	1.55e-05	0.000115	CcSEcCtD
Doxepin—Skin disorder—Epirubicin—breast cancer	1.55e-05	0.000115	CcSEcCtD
Doxepin—Hyperhidrosis—Epirubicin—breast cancer	1.54e-05	0.000114	CcSEcCtD
Doxepin—Insomnia—Methotrexate—breast cancer	1.54e-05	0.000114	CcSEcCtD
Doxepin—Chest pain—Doxorubicin—breast cancer	1.54e-05	0.000114	CcSEcCtD
Doxepin—Myalgia—Doxorubicin—breast cancer	1.54e-05	0.000114	CcSEcCtD
Doxepin—Arthralgia—Doxorubicin—breast cancer	1.54e-05	0.000114	CcSEcCtD
Doxepin—Anxiety—Doxorubicin—breast cancer	1.53e-05	0.000114	CcSEcCtD
Doxepin—Paraesthesia—Methotrexate—breast cancer	1.53e-05	0.000113	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	1.53e-05	0.000113	CcSEcCtD
Doxepin—Discomfort—Doxorubicin—breast cancer	1.52e-05	0.000113	CcSEcCtD
Doxepin—Anorexia—Epirubicin—breast cancer	1.52e-05	0.000113	CcSEcCtD
Doxepin—Dyspnoea—Methotrexate—breast cancer	1.52e-05	0.000113	CcSEcCtD
Doxepin—Somnolence—Methotrexate—breast cancer	1.52e-05	0.000112	CcSEcCtD
Doxepin—Dizziness—Capecitabine—breast cancer	1.51e-05	0.000112	CcSEcCtD
Doxepin—Dry mouth—Doxorubicin—breast cancer	1.51e-05	0.000112	CcSEcCtD
Doxepin—Vomiting—Docetaxel—breast cancer	1.5e-05	0.000111	CcSEcCtD
Doxepin—Dyspepsia—Methotrexate—breast cancer	1.5e-05	0.000111	CcSEcCtD
Doxepin—Rash—Docetaxel—breast cancer	1.49e-05	0.00011	CcSEcCtD
Doxepin—Hypotension—Epirubicin—breast cancer	1.49e-05	0.00011	CcSEcCtD
Doxepin—Dermatitis—Docetaxel—breast cancer	1.49e-05	0.00011	CcSEcCtD
Doxepin—Confusional state—Doxorubicin—breast cancer	1.49e-05	0.00011	CcSEcCtD
Doxepin—Decreased appetite—Methotrexate—breast cancer	1.48e-05	0.00011	CcSEcCtD
Doxepin—Headache—Docetaxel—breast cancer	1.48e-05	0.00011	CcSEcCtD
Doxepin—Oedema—Doxorubicin—breast cancer	1.48e-05	0.000109	CcSEcCtD
Doxepin—Gastrointestinal disorder—Methotrexate—breast cancer	1.47e-05	0.000109	CcSEcCtD
Doxepin—Fatigue—Methotrexate—breast cancer	1.47e-05	0.000109	CcSEcCtD
Doxepin—Infection—Doxorubicin—breast cancer	1.47e-05	0.000109	CcSEcCtD
Doxepin—Pain—Methotrexate—breast cancer	1.46e-05	0.000108	CcSEcCtD
Doxepin—Vomiting—Capecitabine—breast cancer	1.46e-05	0.000108	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Epirubicin—breast cancer	1.45e-05	0.000108	CcSEcCtD
Doxepin—Shock—Doxorubicin—breast cancer	1.45e-05	0.000108	CcSEcCtD
Doxepin—Nervous system disorder—Doxorubicin—breast cancer	1.45e-05	0.000107	CcSEcCtD
Doxepin—Thrombocytopenia—Doxorubicin—breast cancer	1.44e-05	0.000107	CcSEcCtD
Doxepin—Rash—Capecitabine—breast cancer	1.44e-05	0.000107	CcSEcCtD
Doxepin—Insomnia—Epirubicin—breast cancer	1.44e-05	0.000107	CcSEcCtD
Doxepin—Dermatitis—Capecitabine—breast cancer	1.44e-05	0.000107	CcSEcCtD
Doxepin—Tachycardia—Doxorubicin—breast cancer	1.44e-05	0.000107	CcSEcCtD
Doxepin—Headache—Capecitabine—breast cancer	1.43e-05	0.000106	CcSEcCtD
Doxepin—Skin disorder—Doxorubicin—breast cancer	1.43e-05	0.000106	CcSEcCtD
Doxepin—Paraesthesia—Epirubicin—breast cancer	1.43e-05	0.000106	CcSEcCtD
Doxepin—Hyperhidrosis—Doxorubicin—breast cancer	1.43e-05	0.000106	CcSEcCtD
Doxepin—Dyspnoea—Epirubicin—breast cancer	1.42e-05	0.000105	CcSEcCtD
Doxepin—Somnolence—Epirubicin—breast cancer	1.42e-05	0.000105	CcSEcCtD
Doxepin—Anorexia—Doxorubicin—breast cancer	1.41e-05	0.000104	CcSEcCtD
Doxepin—Nausea—Docetaxel—breast cancer	1.4e-05	0.000104	CcSEcCtD
Doxepin—Feeling abnormal—Methotrexate—breast cancer	1.4e-05	0.000104	CcSEcCtD
Doxepin—Dyspepsia—Epirubicin—breast cancer	1.4e-05	0.000104	CcSEcCtD
Doxepin—Gastrointestinal pain—Methotrexate—breast cancer	1.39e-05	0.000103	CcSEcCtD
Doxepin—Decreased appetite—Epirubicin—breast cancer	1.39e-05	0.000103	CcSEcCtD
Doxepin—Hypotension—Doxorubicin—breast cancer	1.38e-05	0.000102	CcSEcCtD
Doxepin—Gastrointestinal disorder—Epirubicin—breast cancer	1.38e-05	0.000102	CcSEcCtD
Doxepin—Fatigue—Epirubicin—breast cancer	1.38e-05	0.000102	CcSEcCtD
Doxepin—Pain—Epirubicin—breast cancer	1.36e-05	0.000101	CcSEcCtD
Doxepin—Constipation—Epirubicin—breast cancer	1.36e-05	0.000101	CcSEcCtD
Doxepin—Nausea—Capecitabine—breast cancer	1.36e-05	0.000101	CcSEcCtD
Doxepin—Urticaria—Methotrexate—breast cancer	1.35e-05	0.0001	CcSEcCtD
Doxepin—Abdominal pain—Methotrexate—breast cancer	1.35e-05	9.98e-05	CcSEcCtD
Doxepin—Body temperature increased—Methotrexate—breast cancer	1.35e-05	9.98e-05	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Doxorubicin—breast cancer	1.34e-05	9.96e-05	CcSEcCtD
Doxepin—Insomnia—Doxorubicin—breast cancer	1.33e-05	9.89e-05	CcSEcCtD
Doxepin—Paraesthesia—Doxorubicin—breast cancer	1.33e-05	9.81e-05	CcSEcCtD
Doxepin—Dyspnoea—Doxorubicin—breast cancer	1.32e-05	9.74e-05	CcSEcCtD
Doxepin—Feeling abnormal—Epirubicin—breast cancer	1.31e-05	9.73e-05	CcSEcCtD
Doxepin—Somnolence—Doxorubicin—breast cancer	1.31e-05	9.72e-05	CcSEcCtD
Doxepin—Gastrointestinal pain—Epirubicin—breast cancer	1.3e-05	9.66e-05	CcSEcCtD
Doxepin—Dyspepsia—Doxorubicin—breast cancer	1.3e-05	9.62e-05	CcSEcCtD
Doxepin—Decreased appetite—Doxorubicin—breast cancer	1.28e-05	9.5e-05	CcSEcCtD
Doxepin—Gastrointestinal disorder—Doxorubicin—breast cancer	1.27e-05	9.44e-05	CcSEcCtD
Doxepin—Fatigue—Doxorubicin—breast cancer	1.27e-05	9.42e-05	CcSEcCtD
Doxepin—Urticaria—Epirubicin—breast cancer	1.27e-05	9.38e-05	CcSEcCtD
Doxepin—Pain—Doxorubicin—breast cancer	1.26e-05	9.35e-05	CcSEcCtD
Doxepin—Constipation—Doxorubicin—breast cancer	1.26e-05	9.35e-05	CcSEcCtD
Doxepin—Body temperature increased—Epirubicin—breast cancer	1.26e-05	9.34e-05	CcSEcCtD
Doxepin—Abdominal pain—Epirubicin—breast cancer	1.26e-05	9.34e-05	CcSEcCtD
Doxepin—Hypersensitivity—Methotrexate—breast cancer	1.26e-05	9.3e-05	CcSEcCtD
Doxepin—Asthenia—Methotrexate—breast cancer	1.22e-05	9.06e-05	CcSEcCtD
Doxepin—Feeling abnormal—Doxorubicin—breast cancer	1.22e-05	9.01e-05	CcSEcCtD
Doxepin—Gastrointestinal pain—Doxorubicin—breast cancer	1.21e-05	8.94e-05	CcSEcCtD
Doxepin—Pruritus—Methotrexate—breast cancer	1.21e-05	8.93e-05	CcSEcCtD
Doxepin—Hypersensitivity—Epirubicin—breast cancer	1.18e-05	8.7e-05	CcSEcCtD
Doxepin—Urticaria—Doxorubicin—breast cancer	1.17e-05	8.68e-05	CcSEcCtD
Doxepin—Abdominal pain—Doxorubicin—breast cancer	1.17e-05	8.64e-05	CcSEcCtD
Doxepin—Body temperature increased—Doxorubicin—breast cancer	1.17e-05	8.64e-05	CcSEcCtD
Doxepin—Diarrhoea—Methotrexate—breast cancer	1.17e-05	8.64e-05	CcSEcCtD
Doxepin—Asthenia—Epirubicin—breast cancer	1.14e-05	8.48e-05	CcSEcCtD
Doxepin—Pruritus—Epirubicin—breast cancer	1.13e-05	8.36e-05	CcSEcCtD
Doxepin—Dizziness—Methotrexate—breast cancer	1.13e-05	8.35e-05	CcSEcCtD
Doxepin—Diarrhoea—Epirubicin—breast cancer	1.09e-05	8.08e-05	CcSEcCtD
Doxepin—Hypersensitivity—Doxorubicin—breast cancer	1.09e-05	8.05e-05	CcSEcCtD
Doxepin—Vomiting—Methotrexate—breast cancer	1.08e-05	8.03e-05	CcSEcCtD
Doxepin—Rash—Methotrexate—breast cancer	1.07e-05	7.96e-05	CcSEcCtD
Doxepin—Dermatitis—Methotrexate—breast cancer	1.07e-05	7.95e-05	CcSEcCtD
Doxepin—Headache—Methotrexate—breast cancer	1.07e-05	7.91e-05	CcSEcCtD
Doxepin—Asthenia—Doxorubicin—breast cancer	1.06e-05	7.84e-05	CcSEcCtD
Doxepin—Dizziness—Epirubicin—breast cancer	1.05e-05	7.81e-05	CcSEcCtD
Doxepin—Pruritus—Doxorubicin—breast cancer	1.04e-05	7.73e-05	CcSEcCtD
Doxepin—Vomiting—Epirubicin—breast cancer	1.01e-05	7.51e-05	CcSEcCtD
Doxepin—Nausea—Methotrexate—breast cancer	1.01e-05	7.5e-05	CcSEcCtD
Doxepin—Diarrhoea—Doxorubicin—breast cancer	1.01e-05	7.48e-05	CcSEcCtD
Doxepin—Rash—Epirubicin—breast cancer	1.01e-05	7.45e-05	CcSEcCtD
Doxepin—Dermatitis—Epirubicin—breast cancer	1e-05	7.44e-05	CcSEcCtD
Doxepin—Headache—Epirubicin—breast cancer	9.99e-06	7.4e-05	CcSEcCtD
Doxepin—Dizziness—Doxorubicin—breast cancer	9.76e-06	7.23e-05	CcSEcCtD
Doxepin—Nausea—Epirubicin—breast cancer	9.47e-06	7.02e-05	CcSEcCtD
Doxepin—Vomiting—Doxorubicin—breast cancer	9.38e-06	6.95e-05	CcSEcCtD
Doxepin—Rash—Doxorubicin—breast cancer	9.31e-06	6.89e-05	CcSEcCtD
Doxepin—Dermatitis—Doxorubicin—breast cancer	9.3e-06	6.89e-05	CcSEcCtD
Doxepin—Headache—Doxorubicin—breast cancer	9.25e-06	6.85e-05	CcSEcCtD
Doxepin—Nausea—Doxorubicin—breast cancer	8.77e-06	6.49e-05	CcSEcCtD
Doxepin—HTR2A—Signaling by GPCR—AKT1—breast cancer	7.95e-07	1.07e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—EGFR—breast cancer	7.94e-07	1.07e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TP53—breast cancer	7.94e-07	1.07e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—AKT1—breast cancer	7.93e-07	1.07e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MAPK8—breast cancer	7.93e-07	1.06e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ABCB1—breast cancer	7.91e-07	1.06e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—AKT1—breast cancer	7.9e-07	1.06e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MAPK8—breast cancer	7.9e-07	1.06e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CASP3—breast cancer	7.89e-07	1.06e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—AKT1—breast cancer	7.88e-07	1.06e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL2—breast cancer	7.88e-07	1.06e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—NOS3—breast cancer	7.87e-07	1.06e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TP53—breast cancer	7.85e-07	1.05e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—HRAS—breast cancer	7.84e-07	1.05e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—IL6—breast cancer	7.84e-07	1.05e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MYC—breast cancer	7.84e-07	1.05e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MAPK8—breast cancer	7.82e-07	1.05e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TGFB1—breast cancer	7.82e-07	1.05e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—AKT1—breast cancer	7.8e-07	1.05e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MAPK8—breast cancer	7.8e-07	1.05e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MAPK3—breast cancer	7.8e-07	1.05e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MYC—breast cancer	7.8e-07	1.05e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—AKT1—breast cancer	7.78e-07	1.05e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TGFB1—breast cancer	7.78e-07	1.04e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—TYMS—breast cancer	7.77e-07	1.04e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	7.75e-07	1.04e-05	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—PIK3CA—breast cancer	7.7e-07	1.03e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—NOS3—breast cancer	7.68e-07	1.03e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—NCOR1—breast cancer	7.68e-07	1.03e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PLA2G4A—breast cancer	7.68e-07	1.03e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GSTM1—breast cancer	7.68e-07	1.03e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CCND1—breast cancer	7.68e-07	1.03e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—SRC—breast cancer	7.68e-07	1.03e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MAPK3—breast cancer	7.67e-07	1.03e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PIK3CD—breast cancer	7.67e-07	1.03e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—EGFR—breast cancer	7.66e-07	1.03e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—JUN—breast cancer	7.66e-07	1.03e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—PIK3CA—breast cancer	7.63e-07	1.03e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—EGFR—breast cancer	7.62e-07	1.02e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CTNNB1—breast cancer	7.6e-07	1.02e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PIK3CD—breast cancer	7.6e-07	1.02e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—HRAS—breast cancer	7.59e-07	1.02e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MYC—breast cancer	7.58e-07	1.02e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—ALB—breast cancer	7.57e-07	1.02e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TGFB1—breast cancer	7.56e-07	1.02e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—SRC—breast cancer	7.55e-07	1.01e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—SRC—breast cancer	7.54e-07	1.01e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—SRC—breast cancer	7.51e-07	1.01e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—HRAS—breast cancer	7.51e-07	1.01e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—IL6—breast cancer	7.51e-07	1.01e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—ALB—breast cancer	7.5e-07	1.01e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—KRAS—breast cancer	7.5e-07	1.01e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—SRC—breast cancer	7.49e-07	1.01e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—VEGFA—breast cancer	7.48e-07	1e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MYC—breast cancer	7.46e-07	1e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MMP9—breast cancer	7.45e-07	1e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TGFB1—breast cancer	7.44e-07	1e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CDKN1A—breast cancer	7.43e-07	9.98e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—SRC—breast cancer	7.42e-07	9.96e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—EGFR—breast cancer	7.42e-07	9.96e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—PTEN—breast cancer	7.41e-07	9.95e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—STAT3—breast cancer	7.4e-07	9.95e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—SRC—breast cancer	7.4e-07	9.94e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3CG—breast cancer	7.39e-07	9.93e-06	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TP53—breast cancer	7.38e-07	9.92e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—VEGFA—breast cancer	7.36e-07	9.88e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—GPX1—breast cancer	7.35e-07	9.88e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—VEGFA—breast cancer	7.34e-07	9.86e-06	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—AKT1—breast cancer	7.34e-07	9.86e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—VEGFA—breast cancer	7.32e-07	9.83e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—EGFR—breast cancer	7.3e-07	9.8e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—VEGFA—breast cancer	7.29e-07	9.8e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—STAT3—breast cancer	7.28e-07	9.79e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CYP1A1—breast cancer	7.28e-07	9.78e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—STAT3—breast cancer	7.27e-07	9.76e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PIK3CB—breast cancer	7.27e-07	9.76e-06	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—IL6—breast cancer	7.26e-07	9.76e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MAPK8—breast cancer	7.25e-07	9.74e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—STAT3—breast cancer	7.25e-07	9.73e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—NOS3—breast cancer	7.24e-07	9.73e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—KRAS—breast cancer	7.24e-07	9.73e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—AKT1—breast cancer	7.23e-07	9.71e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—VEGFA—breast cancer	7.22e-07	9.7e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—STAT3—breast cancer	7.22e-07	9.7e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ERCC2—breast cancer	7.22e-07	9.7e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—VEGFA—breast cancer	7.2e-07	9.68e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—KRAS—breast cancer	7.2e-07	9.68e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PTGS2—breast cancer	7.2e-07	9.67e-06	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—IL6—breast cancer	7.19e-07	9.66e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—NOS3—breast cancer	7.18e-07	9.64e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—STAT3—breast cancer	7.15e-07	9.61e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—STAT3—breast cancer	7.13e-07	9.58e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PIK3CB—breast cancer	7.09e-07	9.53e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MAPK3—breast cancer	7.07e-07	9.5e-06	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—HRAS—breast cancer	7.06e-07	9.49e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PTGS2—breast cancer	7.03e-07	9.44e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—KRAS—breast cancer	7.01e-07	9.41e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MAPK3—breast cancer	6.96e-07	9.35e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MAPK3—breast cancer	6.94e-07	9.33e-06	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—AKT1—breast cancer	6.92e-07	9.3e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MAPK3—breast cancer	6.92e-07	9.3e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MAPK3—breast cancer	6.9e-07	9.27e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—KRAS—breast cancer	6.89e-07	9.26e-06	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—PIK3CA—breast cancer	6.89e-07	9.26e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MYC—breast cancer	6.88e-07	9.24e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—SRC—breast cancer	6.87e-07	9.23e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TGFB1—breast cancer	6.86e-07	9.22e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MAPK3—breast cancer	6.83e-07	9.18e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MAPK3—breast cancer	6.81e-07	9.15e-06	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—PIK3CA—breast cancer	6.81e-07	9.15e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—MTHFR—breast cancer	6.79e-07	9.12e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MYC—breast cancer	6.77e-07	9.09e-06	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—IL6—breast cancer	6.76e-07	9.08e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MYC—breast cancer	6.75e-07	9.07e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TGFB1—breast cancer	6.75e-07	9.07e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TGFB1—breast cancer	6.74e-07	9.05e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MYC—breast cancer	6.73e-07	9.04e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—EGFR—breast cancer	6.73e-07	9.04e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TGFB1—breast cancer	6.72e-07	9.02e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MYC—breast cancer	6.71e-07	9.02e-06	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—AKT1—breast cancer	6.7e-07	9e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TGFB1—breast cancer	6.7e-07	8.99e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—VEGFA—breast cancer	6.69e-07	8.99e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PIK3CB—breast cancer	6.68e-07	8.98e-06	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TP53—breast cancer	6.67e-07	8.95e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—PIK3CA—breast cancer	6.65e-07	8.94e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MYC—breast cancer	6.65e-07	8.93e-06	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—AKT1—breast cancer	6.63e-07	8.91e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TGFB1—breast cancer	6.63e-07	8.91e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MYC—breast cancer	6.63e-07	8.9e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—STAT3—breast cancer	6.63e-07	8.9e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PIK3CB—breast cancer	6.63e-07	8.9e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PTGS2—breast cancer	6.62e-07	8.9e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—EGFR—breast cancer	6.62e-07	8.89e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—PIK3CA—breast cancer	6.62e-07	8.89e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TGFB1—breast cancer	6.61e-07	8.88e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—EGFR—breast cancer	6.61e-07	8.87e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—EGFR—breast cancer	6.59e-07	8.85e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PTGS2—breast cancer	6.56e-07	8.82e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—EGFR—breast cancer	6.56e-07	8.82e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—EGFR—breast cancer	6.5e-07	8.73e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3CD—breast cancer	6.5e-07	8.73e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—EGFR—breast cancer	6.48e-07	8.71e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—PIK3CA—breast cancer	6.44e-07	8.65e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TP53—breast cancer	6.43e-07	8.64e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—ALB—breast cancer	6.41e-07	8.61e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TP53—breast cancer	6.4e-07	8.6e-06	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—HRAS—breast cancer	6.38e-07	8.56e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—KRAS—breast cancer	6.36e-07	8.54e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—PIK3CA—breast cancer	6.33e-07	8.51e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MAPK3—breast cancer	6.33e-07	8.51e-06	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—AKT1—breast cancer	6.29e-07	8.45e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PTEN—breast cancer	6.28e-07	8.43e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—CAV1—breast cancer	6.26e-07	8.41e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—KRAS—breast cancer	6.25e-07	8.4e-06	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—PIK3CA—breast cancer	6.25e-07	8.4e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—KRAS—breast cancer	6.24e-07	8.38e-06	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—AKT1—breast cancer	6.23e-07	8.38e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TP53—breast cancer	6.23e-07	8.36e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—KRAS—breast cancer	6.22e-07	8.36e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—KRAS—breast cancer	6.2e-07	8.33e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MYC—breast cancer	6.16e-07	8.27e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—HRAS—breast cancer	6.15e-07	8.27e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TGFB1—breast cancer	6.14e-07	8.25e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—KRAS—breast cancer	6.14e-07	8.25e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—NOS3—breast cancer	6.13e-07	8.24e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PTEN—breast cancer	6.13e-07	8.23e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TP53—breast cancer	6.13e-07	8.23e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—KRAS—breast cancer	6.12e-07	8.23e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—HRAS—breast cancer	6.12e-07	8.22e-06	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IL6—breast cancer	6.1e-07	8.2e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—EGFR—breast cancer	6.02e-07	8.09e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—HRAS—breast cancer	5.95e-07	8e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IL6—breast cancer	5.89e-07	7.91e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—HRAS—breast cancer	5.86e-07	7.87e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IL6—breast cancer	5.86e-07	7.87e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—PIK3CA—breast cancer	5.84e-07	7.85e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PTEN—breast cancer	5.78e-07	7.76e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—PIK3CA—breast cancer	5.75e-07	7.72e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—PIK3CA—breast cancer	5.73e-07	7.7e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PTEN—breast cancer	5.73e-07	7.69e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—PIK3CA—breast cancer	5.72e-07	7.68e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3CG—breast cancer	5.7e-07	7.66e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IL6—breast cancer	5.7e-07	7.66e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—PIK3CA—breast cancer	5.7e-07	7.65e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—KRAS—breast cancer	5.69e-07	7.64e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3CB—breast cancer	5.66e-07	7.61e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TP53—breast cancer	5.65e-07	7.59e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—PIK3CA—breast cancer	5.64e-07	7.58e-06	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—AKT1—breast cancer	5.63e-07	7.56e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—PIK3CA—breast cancer	5.63e-07	7.56e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PTGS2—breast cancer	5.61e-07	7.54e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IL6—breast cancer	5.61e-07	7.53e-06	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—AKT1—breast cancer	5.57e-07	7.48e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TP53—breast cancer	5.56e-07	7.47e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TP53—breast cancer	5.55e-07	7.45e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TP53—breast cancer	5.53e-07	7.43e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TP53—breast cancer	5.51e-07	7.4e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TP53—breast cancer	5.46e-07	7.33e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TP53—breast cancer	5.44e-07	7.31e-06	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—AKT1—breast cancer	5.43e-07	7.3e-06	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—AKT1—breast cancer	5.41e-07	7.26e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—HRAS—breast cancer	5.4e-07	7.26e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—HRAS—breast cancer	5.32e-07	7.14e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—HRAS—breast cancer	5.31e-07	7.13e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—HRAS—breast cancer	5.29e-07	7.1e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—HRAS—breast cancer	5.27e-07	7.08e-06	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—AKT1—breast cancer	5.26e-07	7.06e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—PIK3CA—breast cancer	5.23e-07	7.02e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—HRAS—breast cancer	5.22e-07	7.01e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—HRAS—breast cancer	5.21e-07	6.99e-06	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—AKT1—breast cancer	5.17e-07	6.95e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IL6—breast cancer	5.17e-07	6.95e-06	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—AKT1—breast cancer	5.11e-07	6.86e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IL6—breast cancer	5.09e-07	6.84e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IL6—breast cancer	5.08e-07	6.82e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IL6—breast cancer	5.06e-07	6.8e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TP53—breast cancer	5.06e-07	6.79e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IL6—breast cancer	5.05e-07	6.78e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3CD—breast cancer	5.01e-07	6.73e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IL6—breast cancer	5e-07	6.71e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL6—breast cancer	4.98e-07	6.69e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ALB—breast cancer	4.95e-07	6.65e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PTEN—breast cancer	4.89e-07	6.57e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—HRAS—breast cancer	4.84e-07	6.5e-06	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—AKT1—breast cancer	4.77e-07	6.41e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—NOS3—breast cancer	4.73e-07	6.36e-06	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—AKT1—breast cancer	4.69e-07	6.31e-06	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—AKT1—breast cancer	4.68e-07	6.29e-06	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—AKT1—breast cancer	4.67e-07	6.27e-06	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—AKT1—breast cancer	4.65e-07	6.25e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL6—breast cancer	4.63e-07	6.22e-06	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—AKT1—breast cancer	4.61e-07	6.19e-06	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—AKT1—breast cancer	4.6e-07	6.17e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PIK3CA—breast cancer	4.43e-07	5.95e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3CB—breast cancer	4.37e-07	5.87e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PTGS2—breast cancer	4.33e-07	5.82e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PIK3CA—breast cancer	4.32e-07	5.81e-06	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—AKT1—breast cancer	4.27e-07	5.74e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PIK3CA—breast cancer	4.07e-07	5.47e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PIK3CA—breast cancer	4.04e-07	5.43e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PTEN—breast cancer	3.78e-07	5.07e-06	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—AKT1—breast cancer	3.62e-07	4.86e-06	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—AKT1—breast cancer	3.53e-07	4.74e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PIK3CA—breast cancer	3.45e-07	4.64e-06	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—AKT1—breast cancer	3.33e-07	4.47e-06	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—AKT1—breast cancer	3.3e-07	4.43e-06	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—AKT1—breast cancer	2.82e-07	3.79e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PIK3CA—breast cancer	2.66e-07	3.58e-06	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—AKT1—breast cancer	2.18e-07	2.92e-06	CbGpPWpGaD
